• 011-26907444
  • raghava@iiitd.ac.in

Welcome to Peptide Card of AntiTbPdb

This page displays user query in tabular form.

FWGALAKGALKLIGPGSLFSSFSKKD details
Primary information
ID antitb_1189,
Name25019413
N-Terminal modificationPin2 [GPG]
C-Terminal ModificationFWGALAKGALKLIGPGSLFSSFSKKD
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature26
SourceL
OriginCationic
SpeciesSynthetic
StrainAmino acid substitution at one postion of Pin2 (P at 14 by GPG)
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis H37Rv
Cell LineMIC = 80.1 ± 24.8 μg/ml or 29 ± 9 μM
Inhibition ConcentrationIn vitro
Sequence2014
CytotoxicityRBC
In vivo ModelNA
Lethal DoseHemolysis ( IC-50 = 46.6 [34–64] )
Immune ResponceNone
Mechanism of ActionNA
TargetNA
Combination TherapyCell wall disruption
Other activitiesCell wall
PMIDNone
Year of PublicationAnti-bacterial (E. coli, S. aureus)
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1190,
Name25019413
N-Terminal modificationPin2 [GPG]
C-Terminal ModificationFWGALAKGALKLIGPGSLFSSFSKKD
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature26
SourceL
OriginCationic
SpeciesSynthetic
StrainAmino acid substitution at one postion of Pin2 (P at 14 by GPG)
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis muti-drug resistant strain (MDR) clinical isolate
Cell LineMIC = 48.1 μg/ml or 17.4 μM
Inhibition ConcentrationIn vitro
Sequence2014
CytotoxicityRBC
In vivo ModelNA
Lethal DoseHemolysis ( IC-50 = 46.6 [34–64] )
Immune ResponceNone
Mechanism of ActionNA
TargetNA
Combination TherapyCell wall disruption
Other activitiesCell wall
PMIDNone
Year of PublicationAnti-bacterial (E. coli, S. aureus)
Tertiary Structure
(Technique)
Not Predicted),